Glycol-Epoetin
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Forecasting the Biological Effect of PEGylated-rHuEPO Candidates in Chronic Kidney Disease Patients using a Middle-out Translation Approach.
Journal: Pharmaceutical research
Published: September 27, 2025
Comparative Safety of Long-Acting Versus Short-Acting Erythropoiesis-Stimulating Agents (ESA): Disproportionality Analysis Using the FDA Adverse Event Reporting System.
Journal: Journal of patient safety
Published: July 17, 2025
Comparative effectiveness of darbepoetin vs other agents in chronic kidney disease-related anemia: a systematic review and network meta-analysis.
Journal: BMC nephrology
Published: June 20, 2025
Effect of Erythropoiesis-Stimulating Agent Types on Hemoglobin Variability in Hemodialysis Patients.
Effect of Erythropoiesis-Stimulating Agent Types on Hemoglobin Variability in Hemodialysis Patients.
Journal: Journal of clinical medicine
Published: May 18, 2025
Transcriptomic Biomarkers in Blood Indicative of the Administration of Recombinant Human Erythropoietin to Thoroughbred Horses.
Journal: Drug testing and analysis
Published: April 03, 2025
Vadadustat (Vafseo) for anemia of chronic kidney disease.
Journal: The Medical letter on drugs and therapeutics
Published: February 13, 2025
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 Trial.
Journal: Nephrology (Carlton, Vic.)
Published: October 02, 2024
Pharmacokinetic and pharmacodynamic modelling of continuous erythropoiesis receptor activator in children: A comprehensive analysis and real-world data validation.
Journal: British journal of clinical pharmacology
Published: August 16, 2024
Discovery of Biomarkers of a Recombinant Human Erythropoietin Administration to Thoroughbred Geldings by Label-Free Proteomics.
Journal: Drug testing and analysis
Published: April 26, 2024
New Transcriptomic Biomarkers for Detection of the Recombinant Human Erythropoietin (rHuEPO) MirCERA in Horses.
Journal: Drug testing and analysis
Published: March 27, 2024
Daprodustat (Jesduvroq) for anemia of chronic kidney disease.
Journal: The Medical letter on drugs and therapeutics
Published: February 27, 2024
Last Updated: 04/28/2026